MSL Teams Will Struggle to Deliver Their Potential Value to the Company without the Correct Leadership.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c38923) has announced the addition of Next-Generation MSL See multiple single-level. Programs: Performance Metrics Performance metrics are measures of an organizations activities and performance. Performance metrics should support a range of stakeholder needs from customers, shareholders to employees [1]. and Value to their offering. The earliest steps to build successful thought leader management and MSL programs are taken well before a pharmaceutical company hires its first MSL and sends him into the field to cultivate relationships with key influencers. Establishing the program's optimal organizational structure To comply with Wikipedia's lead section guidelines, one should be written. and reporting relationships is just as important as understanding how many investigator-led trials the MSL team pioneers or how many new opinion leaders the company adds to its roster. Without the proper leadership, organizational voice and strategy, thought leader management and MSL teams will struggle to deliver their potential value to the company, its product teams and new research objectives. One of the basic tenets for establishing a formal MSL team is its unbiased approach to furthering scientific research within a therapeutic area or disease state. As is often the case, MSL teams are organizationally connected to an overarching commercial organization through the company's thought leader management function. A current trend, however, has seen formal MSL programs emerging from under the marketing umbrella to establish groups independent of marketing's influence. The reason many companies have been separating their MSL programs from their commercial operations is to create an unbiased resource to help opinion leaders expand research within their specialty or therapeutic area. Survey data currently indicate that 60% of participating companies structure their field-based MSL programs under medical affairs to further accentuate the function's scientific emphasis. The nature of thought leader interactions makes it difficult to measure their impact or performance. MSL programs invest many months and years to cultivate strong thought leader relationships that affect strategic decision-making and bottom line results. Due to the extended period of time involved, however, companies are often unable to accurately track performance and thought leader impact. Profiled companies provided insight into the early steps they have taken to begin to understand and measure thought leader impact. Profiled Companies: - AstraZeneca - Bayer - Boehringer-Ingelheim - Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were - Genentech - Johnson & Johnson Medical - INO Ino (ī`nō), in Greek mythology, daughter of Cadmus. She was the wife of Athamas, to whom she bore Learchus and Melicertes. She plotted to kill her stepchildren, Phrixus and Helle, but their mother, Nephele, saved them with the help of a winged Therapeutics - Lundbeck - Novartis - Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest - Organon or·ga·non or or·ga·num n. pl. or·ga·nons or or·ga·nums or or·ga·na 1. An organ. 2. A set of principles for use in scientific investigation. organon pl. organa [Gr.] organ. - P&G Pharmaceuticals - Ranbaxy Labs - Sepracor - Solvay - TAP Pharmaceuticals TAP Pharmaceuticals is an Japanese pharmaceutical company. It is a joint venture between Abbott Laboratories and the Japanese Takeda Pharmaceutical Company, formed in 1977. - Wyeth For more information visit http://www.researchandmarkets.com/reports/c38923 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion